How to buy Ortho Clinical Diagnostics stock

Ortho Clinical Diagnostics Holdings plc is a diagnostics & research business based in the US. Ortho Clinical Diagnostics shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics employs 4,500 staff and has a trailing 12-month revenue of around $1.9 billion.

Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Ortho Clinical Diagnostics stock price (NASDAQ: OCDX)

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics shares at a glance

• Key figures

Information last updated 2021-05-26.

Latest market close	$17.63
52-week range	$15.14 - $21.82
50-day moving average more info button	$19.71
200-day moving average more info button	$18.56
Wall St. target price	$24.82
PE ratio more info button	N/A
Dividend yield more info button	N/A (0%)
Earnings per share (TTM) more info button	N/A

Buy Ortho Clinical Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ortho Clinical Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ortho Clinical Diagnostics price performance over time

Historical closes compared with the close of $17.63 from 2022-05-26

1 week (2022-09-17)	N/A
1 month (2022-08-24)	N/A
3 months (2022-06-24)	N/A
6 months (2022-03-28)	-4.13%

1 year (2021-09-27)	-5.11%
2 years (2020-09-24)	N/A
3 years (2019-09-24)	N/A
5 years (2017-09-24)	N/A

Is Ortho Clinical Diagnostics stock undervalued or overvalued?

Valuing Ortho Clinical Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics's EBITDA

Ortho Clinical Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.9 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics's EBITDA into context you can compare it against that of similar companies.

• Trinity Biotech (TRIB.US): USD$8 million
• Meridian Bioscience (VIVO.US): USD$102.1 million
• IDEXX Laboratories (IDXX.US): USD$961.4 million

Ortho Clinical Diagnostics financials

Revenue TTM	$1.9 billion
Operating margin TTM	8.34%
Gross profit TTM	$880.4 million
Return on assets TTM	1.97%
Return on equity TTM	0%
Profit margin	-8.03%
Book value	N/A
Market capitalisation more info button	$4.7 billion

TTM: trailing 12 months

Shorting Ortho Clinical Diagnostics shares

There are currently 2.7 million Ortho Clinical Diagnostics shares held short by investors – that's known as Ortho Clinical Diagnostics's "short interest". This figure is 10.4% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics shares can be evaluated.

Ortho Clinical Diagnostics's "short interest ratio" (SIR)

Ortho Clinical Diagnostics's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics shares traded daily (recently around 869855.22875817). Ortho Clinical Diagnostics's SIR currently stands at 3.06. In other words for every 100,000 Ortho Clinical Diagnostics shares traded daily on the market, roughly 3060 shares are currently held short.

To gain some more context, you can compare Ortho Clinical Diagnostics's short interest ratio against those of similar companies.

However Ortho Clinical Diagnostics's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics shares, or, against the total number of tradable Ortho Clinical Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics shares in existence, roughly 10 shares are currently held short) or 0.0294% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics.

Find out more about how you can short Ortho Clinical Diagnostics stock.

Ortho Clinical Diagnostics share dividends

We're not expecting Ortho Clinical Diagnostics to pay a dividend over the next 12 months.

Ortho Clinical Diagnostics overview

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .

Frequently asked questions

What percentage of Ortho Clinical Diagnostics is owned by insiders or institutions?
Currently 0.453% of Ortho Clinical Diagnostics shares are held by insiders and 99.59% by institutions. How many people work for Ortho Clinical Diagnostics?
Latest data suggests 4,500 work at Ortho Clinical Diagnostics. When does the fiscal year end for Ortho Clinical Diagnostics?
Ortho Clinical Diagnostics's fiscal year ends in December. Where is Ortho Clinical Diagnostics based?
Ortho Clinical Diagnostics's address is: 1001 Route 202, Raritan, NJ, United States, 08869